Tenofovir/emtricitabine

Entity type image
Type: Product
Name: Tenofovir/emtricitabine
First reported Apr 17 2013 - Updated Apr 17 2013 - 1 reports

New Findings Reported from Saku Central Hospital Describe Ad. . .

New Findings Reported from Saku Central Hospital Describe Advances in AIDS/HIV ResearchAIDS/HIV ResearchNewsRx.comBy a News Reporter-Staff News Editor at AIDS Weekly -- Current study results on AIDS/HIV Research have been published. According to news ... [Published Equities.com - Apr 17 2013]

Quotes

...According to news originating from Nagano, Japan, by NewsRx correspondents, research stated, "The efficacy and safety of fixed-dose abacavir/lamivudine against tenofovir emtricitabine, both with once-daily darunavir/ritonavir, was examined in 80 treatment-naive patients with a baseline HIV-1 viral load of more than 100 000 copies/ml. The time to virologic failure by 48 weeks was not different between the two groups."
New Findings Reported from Saku Central Hospital Describe Ad. . . [Published Equities.com - Apr 17 2013]

More Content

All (1) | News (1) | Reports (0) | Blogs (0) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
New Findings Reported from Saku Central Hospita... [Published Equities.com - Apr 17 2013]
1
In Focus
Content Volume
Document Volume
Network
Network
About
Silobreaker
Press Room
Products
Online Service
On-Premises Software
Contact Us
Sales
Support
Legal
Terms of Use
Privacy Policy


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2013 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.